HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Okuda Selected Research

methyl- 2- hydroxyimino- 5- nitro- 6- methoxy- 3- hexeneamide

11/2001Cancer chemopreventive activity of odorine and odorinol from Aglaia odorata.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Okuda Research Topics

Disease

16Neoplasms (Cancer)
06/2018 - 01/2000
5Lymphoma (Lymphomas)
08/2016 - 09/2000
4Melanoma (Melanoma, Malignant)
12/2016 - 12/2001
4Carcinogenesis
12/2001 - 01/2000
2Necrosis
05/2015 - 01/2000
2Inflammation (Inflammations)
05/2015 - 01/2009
2Allergic Rhinitis
01/2009 - 05/2001
2Seasonal Allergic Rhinitis (Hay Fever)
01/2009 - 06/2001
2Chromosomal Instability (Chromosome Stability)
12/2005 - 08/2000
2Chronic Hepatitis C
03/2004 - 01/2000
2Hepatitis
09/2000 - 06/2000
1Hyperthermia
03/2016
1Carcinoma (Carcinomatosis)
07/2015
1Paralysis (Palsy)
07/2015
1Sunburn
12/2011
1Rhinorrhea
01/2009
1Sneezing
01/2009
1Perennial Allergic Rhinitis
12/2008
1Brain Edema (Cerebral Edema)
01/2006
1Brain Contusion
01/2006
1Persistent Infection
09/2001
1Atherosclerosis
09/2001
1Atherosclerotic Plaque (Atheroma)
09/2001
1Peripheral Nervous System Diseases (PNS Diseases)
08/2001
1Infections
06/2001
1Hydronephrosis
05/2001
1Rhinitis
05/2001
1Viremia
06/2000
1Poisoning
04/2000
1Low Cardiac Output
02/2000

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2006 - 01/2000
3AntigensIBA
08/2002 - 12/2001
3Melanoma-Specific AntigensIBA
08/2002 - 12/2001
3Complementary DNA (cDNA)IBA
08/2002 - 12/2001
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2015 - 01/2006
2ImmunosorbentsIBA
05/2015 - 06/2001
2EnzymesIBA
05/2015 - 06/2001
2InterferonsIBA
03/2004 - 01/2000
2Messenger RNA (mRNA)IBA
02/2002 - 12/2001
2Epstein-Barr virus early antigenIBA
12/2001 - 05/2001
1MicroRNAs (MicroRNA)IBA
12/2016
1Adenosine Monophosphate (AMP)IBA
12/2016
1Biological ProductsIBA
12/2016
1Carrier Proteins (Binding Protein)IBA
12/2016
1Microphthalmia-Associated Transcription FactorIBA
12/2016
1alvocidib (flavopiridol)IBA
08/2016
1Cyclin-Dependent Kinases (cdk Proteins)IBA
08/2016
1AlloysIBA
03/2016
1SuspensionsIBA
07/2015
1Interleukin-6 (Interleukin 6)IBA
05/2015
1glycolic acid (glycolate)IBA
12/2011
1Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
01/2009
1pranlukastIBA
01/2009
1Nasal SpraysIBA
12/2008
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2008
1fluticasone furoateFDA Link
12/2008
1Aquaporins (Water Channels)IBA
01/2006
1Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
03/2004
1Monoclonal AntibodiesIBA
08/2002
1NaphthoquinonesIBA
12/2001
1avicenol AIBA
12/2001
1CarcinogensIBA
12/2001
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2001
1Anticarcinogenic AgentsIBA
11/2001
1odorinolIBA
11/2001
1Peroxynitrous Acid (Peroxynitrite)IBA
11/2001
1methyl- 2- hydroxyimino- 5- nitro- 6- methoxy- 3- hexeneamideIBA
11/2001
1anthraceneIBA
11/2001
1Telomerase (Telomerase Reverse Transcriptase)IBA
10/2001
1ThioredoxinsIBA
09/2001
1AntibodiesIBA
09/2001
1AntioxidantsIBA
09/2001
1Protein Disulfide Reductase (Glutathione)IBA
09/2001
1GlutaredoxinsIBA
09/2001
11,1,1-trichloroethaneIBA
08/2001
1AcidsIBA
05/2001
1Pharmaceutical PreparationsIBA
05/2001
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2001
1NucleotidesIBA
03/2001
1DNA (Deoxyribonucleic Acid)IBA
03/2001
1DiarylheptanoidsIBA
10/2000
1myricanoneIBA
10/2000
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2000
1Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2000
1Tumor Suppressor Protein p53IBA
08/2000
1TolueneIBA
04/2000
1Cyclin EIBA
03/2000
1Milrinone (Primacor)FDA LinkGeneric
02/2000
1Dopamine (Intropin)FDA LinkGeneric
02/2000
1ChromatinIBA
01/2000
1Cisplatin (Platino)FDA LinkGeneric
01/2000
1ZeaxanthinsIBA
01/2000
1LycopeneIBA
01/2000

Therapy/Procedure

4Therapeutics
05/2015 - 01/2000
4Immunotherapy
08/2002 - 06/2001
1Oncolytic Virotherapy
06/2018
1Chemoradiotherapy
07/2015
1Lymph Node Excision (Lymph Node Dissection)
07/2015
1Intravenous Infusions
05/2001
1Renal Dialysis (Hemodialysis)
06/2000